Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For ALVO
Valuation Weak
28%
Profitability n.A.
Fin. Growth Weak
17%
Leverage & Liquidity Bad
0%
Per Share Metrics Weak
33%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 58.63 1.18 0.75
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -72.93 -15.76 -9.11
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 29.35 -2.47 -3.49
Cash 480.90 0.24 0.04
Capex 55.92 -0.02 -0.04
Free Cash Flow -3.08 -0.30 -0.29
Revenue -76.72 0.05 0.20
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin -967.36 -0.61 -0.06
Operating Margin -305.76 -5.86 -1.45
ROA 29.15 -0.21 -0.29
ROE 11.94 0.33 0.30
ROIC 55.67 -0.21 -0.48
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of ALVO is permitted for members.
5 Growth
The "Growth Entry" for the Focus of ALVO is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of ALVO is permitted for members.